Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Transdermal therapeutical system comprising physostigmine as active component and process for the production thereof

Transdermal therapeutical system comprising physostigmine as active component and process for the production thereof

US Patent 5089267 · Granted Feb 18, 1992

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for producing active agent administering systems by means of pad printing2025
Microneedle array having an active ingredient in the form of salts2025
Oral dosage form containing theobromine-free cocoa2025
Nicotine-containing transparent transdermal therapeutic system2024
Method of marking film-like dosage forms2024
Over-patch having improved compatibility and a long adhesion duration and method2023
Buprenorphine transdermal delivery system2022
Sealing sheet and adhesive tape for wet rooms2021
Transdermal therapeutic system with fentanyl or related substances2021
Transdermal therapeutic system with fentanyl or related substances2020
Transdermal therapeutic system with fentanyl or related substances2020
Over-patch having improved compatibility and a long adhesion duration and method2019